5 Sample collection kits, test kits and diagnostic reagents for medical and/or clinical use; dna-based diagnostics for the determination and monitoring of human diseases, including but not limited to, candidiasis, chancroid, chlamydia, cytomegalovirus, granuloma inguinale, gonorrhea, hepatitis, herpes, human immunodeficiency virus (HIV), human papillomavirus (HPV), syphilis, and/or trichomoniasis; molecular diagnostic kits used to evaluate a woman's risk of developing cervical cancer; self-administered sample collection technologies; self-testing diagnostics; and research and consultation services in the field of biotechnology, particularly dna probes and PCR analysis for detecting, identifying and treating cervical/vaginal infections, in International Class 5